These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6578358)

  • 1. [Cytogenetic study of the exfoliated cells from urothelial tumor patients: observation of chromosome of exfoliated cells].
    Mitsuhashi H
    Nihon Hinyokika Gakkai Zasshi; 1983 Apr; 74(4):576-95. PubMed ID: 6578358
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of cytology in the diagnosis, management and follow-up of genito-urinary malignancy.
    Singh SM; Mathur BB; Wadhwa SN; Verma K
    Indian J Cancer; 1980 Dec; 17(4):226-9. PubMed ID: 7228105
    [No Abstract]   [Full Text] [Related]  

  • 3. [The role of urinary cytology in the diagnosis of neoplasms of the upper excretory tract. Cyto-histological correlations in 29 cases].
    Mincione GP; Muraro GB; Pecori M; Rossi I
    Pathologica; 1983; 75(1036):181-6. PubMed ID: 6634230
    [No Abstract]   [Full Text] [Related]  

  • 4. Epidermal growth factor in urine from the patients with urothelial tumors.
    Fuse H; Mizuno I; Sakamoto M; Katayama T
    Urol Int; 1992; 48(3):261-4. PubMed ID: 1589913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exfoliative cytology in urine.
    Tsai SY; Laughlin VC; Goodsitt E; Basa A
    J Urol; 1968 Mar; 99(3):342-4. PubMed ID: 4869567
    [No Abstract]   [Full Text] [Related]  

  • 6. [A study on the metabolism of tryptophan in the urine of patients with bladder cancer].
    Okawa M
    Nihon Hinyokika Gakkai Zasshi; 1970 Nov; 61(11):1039-57. PubMed ID: 5530599
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical study of urine NMP 22 (nuclear matrix protein 22) as a tumor marker in urinary epithelial cancer.
    Takeuchi Y; Sawada Y; Yabuki D; Masuda E; Satou D; Kuroda K; Tajima M; Sawamura Y; Matsushima M
    Aktuelle Urol; 2003 Jul; 34(4):265-6. PubMed ID: 14566681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Over expression of CD44V8-10 in urinary exfoliated cells as an independent prognostic predictor in patients with urothelial cancer.
    Miyake H; Eto H; Arakawa S; Kamidono S; Hara I
    J Urol; 2002 Mar; 167(3):1282-7. PubMed ID: 11832714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study on the clinical significance of urinary beta-aminoisobutyric acid in patients with urothelial tumours.
    Nyholm KK; Sjölin KE; Hammer M; Knudsen J; Stahl D; Nielsen HR
    Biomedicine; 1975 Nov; 22(6):509-16. PubMed ID: 1225382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ureteric urine examination.
    Trott PA
    Br J Hosp Med; 1977 May; 17(5):493-7. PubMed ID: 871563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosome analysis in patients with bladder tumor.
    Mićić S; Mićić M; Milasin J
    Urol Int; 1988; 43(4):201-4. PubMed ID: 3188287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voided urine fluorescence in situ hybridization testing for upper tract urothelial carcinoma surveillance.
    Johannes JR; Nelson E; Bibbo M; Bagley DH
    J Urol; 2010 Sep; 184(3):879-82. PubMed ID: 20643443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunocytochemical detection of p53 in cultures of exfoliated cells from urine of patients with urothelial cancers.
    Okuno H; Kakehi Y; Ogawa O; Yamada H; Ozdemir E; Okada Y; Yoshida O
    Jpn J Cancer Res; 1996 Jul; 87(7):718-23. PubMed ID: 8698621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine levels in patients with urinary tract cancer.
    Stefanovic V; Bogicevic M; Stamenic T; Ignjatovic I; Vlahovic P; Mitic M
    Pathol Biol (Paris); 1994 Nov; 42(9):842-6. PubMed ID: 7753593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytological study of the urine in tumors of the kidneys, renal pelvis and bladder].
    Enokhovich VA
    Lab Delo; 1979; (3):150-5. PubMed ID: 85762
    [No Abstract]   [Full Text] [Related]  

  • 16. Human chorionic gonadotropin detected in urinary concentrates from patients with malignant tumors of the testis, prostate, bladder, ureter and kidney.
    Fukutani K; Libby JM; Panko WB; Scardino PT
    J Urol; 1983 Jan; 129(1):74-7. PubMed ID: 6827688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive detection and prediction of bladder cancer by fluorescence in situ hybridization analysis of exfoliated urothelial cells in voided urine.
    Ishiwata S; Takahashi S; Homma Y; Tanaka Y; Kameyama S; Hosaka Y; Kitamura T
    Urology; 2001 Apr; 57(4):811-5. PubMed ID: 11306420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosome changes in bladder cancer: clinical and other correlations.
    Sandberg AA
    Cancer Genet Cytogenet; 1986 Jan; 19(1-2):163-75. PubMed ID: 3455662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescence in situ hybridization (FISH) in the diagnosis of bladder and upper tract urothelial carcinoma: the largest single-institution experience to date.
    Gomella LG; Mann MJ; Cleary RC; Hubosky SG; Bagley DH; Thumar AB; McCue PA; Lallas CD; Trabulsi EJ
    Can J Urol; 2017 Feb; 24(1):8620-8626. PubMed ID: 28263126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.